Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Tries To Curb Rising TCM Ingredient Prices, But Hikes Persist

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - The prices of basic ingredients in traditional Chinese medicines used across China and various other countries in Asia are rising rapidly. Authorities in China have stepped in to control prices but a combination of factors, including the potential profits available in trading TCM ingredients and the growing popularity of TCM globally are driving prices upwards

You may also be interested in...



Traditional Chinese Medicines Seen As Global Growth Opportunity

HONG KONG - Health authorities around the world are working to develop regulatory structures for traditional Chinese medicines

What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 1 of 2)

SHANGHAI - The National Development and Reform Commission, China's state planning agency, charged consumer goods company Unilever a fine of RMB 2 million ($310,000) for price manipulation May 6. The NDRC action was taken in an effort to suppress consumer inflation, but a key takeaway, according to experts, is that multinational companies should be cautious about how they communicate pricing information to the market or they may find themselves in violation of China's Price Law, Anti-Monopoly Law or even foreign antitrust and anti-bribery rules

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

LL1130166

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel